PTEN and hepatocellular carcinoma: The activation of the PI3K/AKT/mTOR pathway in HCC is linked to mutation of PIK3CA [131], mutation, deletion, or downregulation of PTEN and up-regulation of IGF and EGF and of their receptors and related growth factors [132,133].